Bayer Cropscience India Financials

NSE: AGREVOIND | BSE: 530415

₹ --

₹ -- (--%)

As on --

Market cap

₹436 Cr

Revenue (TTM)

₹3,245 Cr

P/E Ratio

1.5

P/B Ratio

3

Div. Yield

1.8 %

Annual
Quarterly

Income Statement ( Cr)	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Operating Revenue	3,245.20	2,725.30	2,272.30	2,137.30	308.76	432.56
Total Income	3,336.10	2,794.20	2,317.60	2,157.80	317.92	437.24
Total Expenditure	2,825.90	2,365.40	2,019.60	1,914.20	281.82	382.45
EBITDA	419.30	359.90	252.70	223.10	26.94	50.12
Depreciation	64.60	36.60	34.00	32.70	5.81	5.59
EBIT	354.70	323.30	218.70	190.40	21.13	44.53
Interest	4.80	3.70	1.70	8.30	9.24	14.76
Other Income	90.90	68.90	45.30	20.50	9.16	4.68
Exceptional Items	--	1,174.70	-57.90	-3.80	0.73	14.86
Profit before Tax	440.80	1,563.20	204.40	198.80	21.78	49.31
Provision for Tax	151.30	401.50	65.40	67.20	7.25	18.39
Profit after Tax	289.50	1,161.70	139.00	131.60	14.53	30.92

Liabilities ( Cr)	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Shareholder's Funds	1,742.30	1,931.30	792.70	673.00	123.37	111.99
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	36.10	47.70	25.60	273.90	101.20	105.82
Current Liabilities	594.60	436.00	1,012.00	606.80	61.82	82.51
Total Liabilities	2,386.90	2,415.00	1,840.70	1,559.70	286.39	300.33

Assets ( Cr)	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Non-Current Assets	520.10	422.80	330.00	426.50	50.94	47.67
Current Assets	1,852.90	1,992.20	1,500.30	1,127.20	235.45	252.66
Total Assets	2,386.90	2,415.00	1,840.70	1,559.70	286.39	300.33
Total Debt*	--	--	--	108.50	98.56	103.33
Net Current Assets	1,258.30	1,556.20	488.30	520.40	173.63	170.14
Contingent Liabilities	219.70	269.90	141.40	113.10	--	5.61

Cashflow ( Cr)	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Cash From Operating Activities	281.50	138.30	106.70	122.30	26.30	71.40
Cash Flow from Investing Activities	-289.70	427.00	88.50	195.10	-4.58	-3.82
Cash from Financing Activities	-479.60	-21.30	-128.50	-32.40	-20.83	-53.70
Net Cash Inflow / Outflow	-487.80	544.00	66.70	285.00	0.88	13.88

Financials Ratios	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Adjusted EPS ()	79.06	294.11	35.19	33.32	10.40	22.13
Cash EPS ()	96.70	303.38	43.80	41.60	14.56	26.14
Adjusted Book Value ()	475.80	488.95	200.69	170.38	88.33	80.18
Dividend per Share ()	5.49	4.99	4.20	4.00	2.00	4.00
Cash Flow per Share ()	76.87	35.01	27.01	30.96	18.83	51.12
Free Cash Flow per Share ()	53.39	231.40	15.70	7.27	14.29	32.34

Profitability Ratios	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
ROCE (%)	24.26	115.04	26.18	41.28	14.19	29.75
ROE (%)	15.76	85.29	18.97	33.05	12.35	27.61
ROA (%)	12.09	54.73	8.22	14.30	4.95	10.29
EBIT Margin (%)	10.93	11.86	9.62	8.91	6.84	10.29
Net Margin (%)	8.68	41.58	6.00	6.10	4.57	7.07
Cash Profit Margin (%)	10.42	42.21	7.32	7.38	6.11	7.83

Growth Ratios	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Revenue Growth (%)	19.08	19.94	6.32	592.22	-28.62	--
EBIT Growth (%)	9.71	47.83	14.86	--	-52.56	--
Net Profit Growth (%)	-75.08	735.76	5.62	805.86	-53.01	--
EPS Growth (%)	-73.12	735.76	5.62	220.32	-53.01	--
Book Value Growth (%)	-9.79	143.64	17.79	445.52	10.16	--

Solvency Ratios	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Debt to Equity	--	--	--	0.16	0.80	0.92
Short term debt to equity ratio	--	--	--	0.16	--	--
Current Ratio	3.12	4.57	1.48	1.86	3.81	3.06
Quick Ratio	2.19	3.42	0.99	1.14	2.25	2.51
Interest Coverage	92.83	423.49	121.24	24.95	3.36	4.34

Operating Efficiency Ratios	Mar-14	Mar-13	Mar-12	Mar-11	Dec-02	Dec-01	Dec-00	Dec-99	Dec-98	Dec-97	Dec-96
Debtors to sales (%)	12.63	11.83	11.27	13.17	30.39	38.97
Asset Turnover	1.42	1.34	1.40	2.42	1.13	1.55
Receivable days	39.32	37.19	41.53	30.77	143.88	131.91
Inventory Days	56.35	64.25	72.38	43.75	77.90	35.91
Payable days	42.61	47.86	69.41	44.80	107.90	85.09
Cash Conversion Cycle	53.05	53.59	44.50	29.71	113.88	82.74